The United states now has now fully vaccinated more than half of its population, leading to a widespread easing of COVID-19 restrictions.
As life returns to some semblance of normal here in the U.S. – with restaurants, bars, casinos, and countless other businesses able to open their doors again – it can be easy to forget that things aren’t the same in other parts of the world.
According to official data, only about 12% of the global population has received at least one vaccine dose.
That means that there are still huge opportunities in those under-vaccinated areas for biotech companies.
And one company just made a big move towards bringing their vaccine to those markets.
Experts have repeatedly said that it will take many vaccines to effectively immunize the world against COVID-19. So, if you thought the profits from developing vaccines was limited to Pfizer Inc. (PFE), Moderna, Inc. (MRNA), and Johnson & Johnson (JNJ), think again.
Last week, Inovio Pharmaceuticals, Inc. (INO) announced a new partnership with Advaccine Biopharmaceuticals to conduct a Phase 3 test of its COVID-19 vaccine, primarily in Latin America and Asia.
The move comes after the U.S. Department of Defense pulled its funding for testing of Inovio’s vaccine earlier this year.
Inovio’s change of tactics to service other parts of the world could have a huge impact on their bottom line. While much depends on whether the vaccine can get an approval for distribution and what its efficacy will be remain to be seen, this is a company to watch as the fight against the pandemic rages on.
Trading tip of the week
When I watch S.C.A.N., I often look for call options being bought in stocks within a similar industry.
Today we saw Calls in Oil and electric vehicle names – both of which were gaining today as the rest of the market was down
That goes to show us that a lot of times the market can go lower, but individual sectors go higher. And sometimes that is where we find our best profit opportunities.
Earnings report to watch
One of the country’s largest grocery store reports its Q1 earnings this week.
The Kroger Co. (KR) has been a huge beneficiary of stay-at-home restrictions during the worst of the pandemic, growing its Earnings per Share an average of 53% over the last three quarters.
But as restrictions ease and more Americans find themselves in restaurant booths rather than grocery aisles, many expect a pullback for Kroger.
Keep an eye out for any surprises, though. An earnings beat could send the stock higher with so many analysts making downward predictions, but the beat would need to be fairly significant to push the stock up from its current heights.
Sound the $1.4 trillion alarm
The American economy is about to go through a projected $1.4 trillion transformation over the next couple of years…
All thanks to the shift to 5G that’s been years in the making.
Most people searching for “best 5G stocks to buy” will end up investing in AT&T, T-Mobile, or Verizon. And they’ll be in for a rude awakening, because profits from investing in 5G directly are almost completely dried up.
Instead, Michael Robinson – a veteran of Silicon Valley for over three decades – has uncovered 20 tiny companies that could see 1,000% gains within eight months. And he’s going to show you why this “backdoor” route is anyone’s best bet to exploit 5G.